The store will not work correctly when cookies are disabled.
4-heptanoyl-3-mesityl-1-oxaspiro[4.4]non-3-en-2-one
ID: ALA2287736
PubChem CID: 76316496
Max Phase: Preclinical
Molecular Formula: C24H32O3
Molecular Weight: 368.52
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCC(=O)C1=C(c2c(C)cc(C)cc2C)C(=O)OC12CCCC2
Standard InChI: InChI=1S/C24H32O3/c1-5-6-7-8-11-19(25)22-21(20-17(3)14-16(2)15-18(20)4)23(26)27-24(22)12-9-10-13-24/h14-15H,5-13H2,1-4H3
Standard InChI Key: IXBNQKKHWPBEMJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
35.8476 -15.9424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6013 -15.6256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5330 -14.8109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7369 -14.6241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3135 -15.3234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9309 -16.1209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9298 -16.9405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6378 -17.3494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3475 -16.9400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3447 -16.1173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6361 -15.7121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6336 -14.8949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2218 -17.3485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0559 -17.3475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0510 -15.7060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8217 -15.9736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8444 -14.6515 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.0630 -14.8908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4096 -14.4000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.0588 -16.7556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8421 -17.5407 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.8760 -16.7454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2934 -17.4479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1105 -17.4377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5280 -18.1402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3451 -18.1300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7625 -18.8325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
11 12 1 0
7 13 1 0
9 14 1 0
10 15 1 0
15 16 2 0
16 5 1 0
5 17 1 0
17 18 1 0
18 15 1 0
18 19 2 0
16 20 1 0
20 21 2 0
20 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 368.52 | Molecular Weight (Monoisotopic): 368.2351 | AlogP: 5.77 | #Rotatable Bonds: 7 |
Polar Surface Area: 43.37 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 7.27 | CX LogD: 7.27 |
Aromatic Rings: 1 | Heavy Atoms: 27 | QED Weighted: 0.45 | Np Likeness Score: 0.32 |
References
1. Zhao JH, Wang ZC, Ji MH, Cheng JL, Zhu GN, Yu CM.. (2012) Synthesis and bioactivity evaluation of novel spiromesifen derivatives., 68 (1): [PMID:21997953] [10.1002/ps.2248] |